NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 174 filers reported holding NEVRO CORP in Q4 2016. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $6,439,000 | +16.4% | 61,685 | -17.8% | 1.14% | +13.3% |
Q2 2016 | $5,532,000 | +53.1% | 75,005 | +16.7% | 1.01% | +44.8% |
Q1 2016 | $3,614,000 | -24.2% | 64,245 | -9.0% | 0.70% | -15.6% |
Q4 2015 | $4,768,000 | +42.5% | 70,621 | -2.1% | 0.82% | +51.4% |
Q3 2015 | $3,346,000 | -51.9% | 72,126 | -44.2% | 0.54% | -45.6% |
Q2 2015 | $6,952,000 | -12.4% | 129,343 | -21.9% | 1.00% | -16.2% |
Q1 2015 | $7,933,000 | +14.7% | 165,512 | -7.5% | 1.20% | +16.5% |
Q4 2014 | $6,917,000 | – | 178,864 | – | 1.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |